REG - Fevertree Drinks PLC - Appointment Of Corporate Broker

Fevertree DrinksAnnouncement

20/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250120:nRST8497Ta&default-theme=true

RNS Number : 8497T  Fevertree Drinks PLC  20 January 2025

20th January 2025

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Appointment Of Corporate Broker

 

Fever-Tree is pleased to announce the appointment of Jefferies International
Limited ("Jefferies") as corporate broker, with immediate effect. Jefferies
will act alongside Investec Bank plc and Morgan Stanley & Co.
International plc.

 Ends

 

For further information:

 

Investor queries

Ann Morris-Gibbons, Director of Investor Relations I ann.hyams@fever-tree.com
I +44 7435 828 138

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

 

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

 

Corporate Broker - Jefferies International Limited

Ed Matthews I Richard Taylor I +44 (0)20 7029 8000

 

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for
alcoholic spirits by retail sales value, with distribution to over 95
countries worldwide. Based in the UK, the brand was launched in 2005 to
provide high quality mixers which could cater to the growing demand for
premium spirits, in particular gin, but also increasingly for vodka, rum and
whisky. The Company now sells a range of carbonated mixers to hotels,
restaurants, bars and cafes ("On Trade") as well as selected retail outlets
("Off Trade").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPUBSBRVAUAAAR